nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—acquired immunodeficiency syndrome	0.242	1	CbGaD
Dronedarone—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0307	0.0626	CbGbCtD
Dronedarone—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0294	0.06	CbGbCtD
Dronedarone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0234	0.0479	CbGbCtD
Dronedarone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0234	0.0478	CbGbCtD
Dronedarone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.022	0.045	CbGbCtD
Dronedarone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.022	0.045	CbGbCtD
Dronedarone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0212	0.0432	CbGbCtD
Dronedarone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0199	0.0407	CbGbCtD
Dronedarone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0199	0.0407	CbGbCtD
Dronedarone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0183	0.0373	CbGbCtD
Dronedarone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0177	0.0362	CbGbCtD
Dronedarone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0172	0.0351	CbGbCtD
Dronedarone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0167	0.0341	CbGbCtD
Dronedarone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.016	0.0327	CbGbCtD
Dronedarone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.016	0.0327	CbGbCtD
Dronedarone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0154	0.0314	CbGbCtD
Dronedarone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0151	0.0308	CbGbCtD
Dronedarone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0151	0.0308	CbGbCtD
Dronedarone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0149	0.0304	CbGbCtD
Dronedarone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.014	0.0286	CbGbCtD
Dronedarone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.014	0.0286	CbGbCtD
Dronedarone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0127	0.0259	CbGbCtD
Dronedarone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0127	0.0259	CbGbCtD
Dronedarone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0119	0.0243	CbGbCtD
Dronedarone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0109	0.0223	CbGbCtD
Dronedarone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0217	CbGbCtD
Dronedarone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00961	0.0196	CbGbCtD
Dronedarone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00961	0.0196	CbGbCtD
Dronedarone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00921	0.0188	CbGbCtD
Dronedarone—CACNA1F—retina—acquired immunodeficiency syndrome	0.0032	0.0358	CbGeAlD
Dronedarone—HCN1—nervous system—acquired immunodeficiency syndrome	0.00302	0.0339	CbGeAlD
Dronedarone—HCN1—central nervous system—acquired immunodeficiency syndrome	0.00291	0.0326	CbGeAlD
Dronedarone—HCN1—brain—acquired immunodeficiency syndrome	0.00231	0.0259	CbGeAlD
Dronedarone—HCN4—nervous system—acquired immunodeficiency syndrome	0.00229	0.0257	CbGeAlD
Dronedarone—HCN3—blood—acquired immunodeficiency syndrome	0.00228	0.0256	CbGeAlD
Dronedarone—HCN4—central nervous system—acquired immunodeficiency syndrome	0.0022	0.0247	CbGeAlD
Dronedarone—HCN2—blood—acquired immunodeficiency syndrome	0.00214	0.024	CbGeAlD
Dronedarone—HCN3—vagina—acquired immunodeficiency syndrome	0.00211	0.0237	CbGeAlD
Dronedarone—HCN2—spinal cord—acquired immunodeficiency syndrome	0.00206	0.0231	CbGeAlD
Dronedarone—HCN3—nervous system—acquired immunodeficiency syndrome	0.00185	0.0208	CbGeAlD
Dronedarone—HCN3—central nervous system—acquired immunodeficiency syndrome	0.00178	0.02	CbGeAlD
Dronedarone—HCN4—brain—acquired immunodeficiency syndrome	0.00175	0.0196	CbGeAlD
Dronedarone—HCN2—nervous system—acquired immunodeficiency syndrome	0.00174	0.0194	CbGeAlD
Dronedarone—HCN2—central nervous system—acquired immunodeficiency syndrome	0.00167	0.0187	CbGeAlD
Dronedarone—HCN3—brain—acquired immunodeficiency syndrome	0.00142	0.0159	CbGeAlD
Dronedarone—CACNB4—spinal cord—acquired immunodeficiency syndrome	0.00135	0.0152	CbGeAlD
Dronedarone—HCN2—brain—acquired immunodeficiency syndrome	0.00133	0.0149	CbGeAlD
Dronedarone—CACNB4—vagina—acquired immunodeficiency syndrome	0.0013	0.0146	CbGeAlD
Dronedarone—CACNB4—lung—acquired immunodeficiency syndrome	0.00123	0.0138	CbGeAlD
Dronedarone—KCNK2—vagina—acquired immunodeficiency syndrome	0.00116	0.0129	CbGeAlD
Dronedarone—CACNB4—nervous system—acquired immunodeficiency syndrome	0.00114	0.0128	CbGeAlD
Dronedarone—CACNB3—digestive system—acquired immunodeficiency syndrome	0.00113	0.0127	CbGeAlD
Dronedarone—CACNB4—central nervous system—acquired immunodeficiency syndrome	0.0011	0.0123	CbGeAlD
Dronedarone—CACNB1—spinal cord—acquired immunodeficiency syndrome	0.00108	0.0121	CbGeAlD
Dronedarone—CACNB2—retina—acquired immunodeficiency syndrome	0.00108	0.0121	CbGeAlD
Dronedarone—CACNB3—blood—acquired immunodeficiency syndrome	0.00108	0.0121	CbGeAlD
Dronedarone—CACNB3—vagina—acquired immunodeficiency syndrome	0.000998	0.0112	CbGeAlD
Dronedarone—CACNB3—lung—acquired immunodeficiency syndrome	0.000944	0.0106	CbGeAlD
Dronedarone—CACNB1—nervous system—acquired immunodeficiency syndrome	0.000912	0.0102	CbGeAlD
Dronedarone—CACNB1—central nervous system—acquired immunodeficiency syndrome	0.000878	0.00983	CbGeAlD
Dronedarone—CACNB3—nervous system—acquired immunodeficiency syndrome	0.000874	0.0098	CbGeAlD
Dronedarone—CACNB4—brain—acquired immunodeficiency syndrome	0.000873	0.00978	CbGeAlD
Dronedarone—CACNB3—central nervous system—acquired immunodeficiency syndrome	0.000842	0.00943	CbGeAlD
Dronedarone—Angioedema—Amprenavir—acquired immunodeficiency syndrome	0.000792	0.0053	CcSEcCtD
Dronedarone—Hypokalaemia—Efavirenz—acquired immunodeficiency syndrome	0.000792	0.0053	CcSEcCtD
Dronedarone—Blood creatinine increased—Delavirdine—acquired immunodeficiency syndrome	0.00078	0.00522	CcSEcCtD
Dronedarone—KCNK2—brain—acquired immunodeficiency syndrome	0.000774	0.00867	CbGeAlD
Dronedarone—CACNB2—digestive system—acquired immunodeficiency syndrome	0.00076	0.00851	CbGeAlD
Dronedarone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000748	0.00838	CbGeAlD
Dronedarone—KCNK2—lymph node—acquired immunodeficiency syndrome	0.000748	0.00838	CbGeAlD
Dronedarone—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000737	0.00494	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.000733	0.00491	CcSEcCtD
Dronedarone—Hepatobiliary disease—Zidovudine—acquired immunodeficiency syndrome	0.000722	0.00483	CcSEcCtD
Dronedarone—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.000717	0.0048	CcSEcCtD
Dronedarone—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000714	0.00478	CcSEcCtD
Dronedarone—Pneumonia—Indinavir—acquired immunodeficiency syndrome	0.000714	0.00478	CcSEcCtD
Dronedarone—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00071	0.00476	CcSEcCtD
Dronedarone—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.000701	0.0047	CcSEcCtD
Dronedarone—CACNB1—brain—acquired immunodeficiency syndrome	0.000697	0.00781	CbGeAlD
Dronedarone—Blood creatinine increased—Saquinavir—acquired immunodeficiency syndrome	0.000694	0.00465	CcSEcCtD
Dronedarone—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.000694	0.00465	CcSEcCtD
Dronedarone—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.000688	0.00461	CcSEcCtD
Dronedarone—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000687	0.0046	CcSEcCtD
Dronedarone—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.000686	0.0046	CcSEcCtD
Dronedarone—SCN1A—spinal cord—acquired immunodeficiency syndrome	0.000678	0.00759	CbGeAlD
Dronedarone—Pneumonia—Efavirenz—acquired immunodeficiency syndrome	0.000674	0.00452	CcSEcCtD
Dronedarone—Hypokalaemia—Saquinavir—acquired immunodeficiency syndrome	0.000674	0.00452	CcSEcCtD
Dronedarone—CACNB1—lymph node—acquired immunodeficiency syndrome	0.000673	0.00754	CbGeAlD
Dronedarone—Dysgeusia—Stavudine—acquired immunodeficiency syndrome	0.000672	0.0045	CcSEcCtD
Dronedarone—Hepatobiliary disease—Indinavir—acquired immunodeficiency syndrome	0.000671	0.00449	CcSEcCtD
Dronedarone—CACNB2—vagina—acquired immunodeficiency syndrome	0.000671	0.00752	CbGeAlD
Dronedarone—CACNB3—brain—acquired immunodeficiency syndrome	0.000668	0.00749	CbGeAlD
Dronedarone—Angioedema—Nevirapine—acquired immunodeficiency syndrome	0.000649	0.00435	CcSEcCtD
Dronedarone—CACNB3—lymph node—acquired immunodeficiency syndrome	0.000646	0.00724	CbGeAlD
Dronedarone—Pneumonia—Delavirdine—acquired immunodeficiency syndrome	0.000645	0.00432	CcSEcCtD
Dronedarone—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.000645	0.00432	CcSEcCtD
Dronedarone—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.000636	0.00426	CcSEcCtD
Dronedarone—CACNB2—lung—acquired immunodeficiency syndrome	0.000634	0.00711	CbGeAlD
Dronedarone—Hepatobiliary disease—Efavirenz—acquired immunodeficiency syndrome	0.000634	0.00425	CcSEcCtD
Dronedarone—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000617	0.00413	CcSEcCtD
Dronedarone—SCN1A—lung—acquired immunodeficiency syndrome	0.000617	0.00691	CbGeAlD
Dronedarone—CACNA1C—digestive system—acquired immunodeficiency syndrome	0.000613	0.00687	CbGeAlD
Dronedarone—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000611	0.00409	CcSEcCtD
Dronedarone—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00061	0.00408	CcSEcCtD
Dronedarone—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000607	0.00407	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000601	0.00402	CcSEcCtD
Dronedarone—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.000596	0.00399	CcSEcCtD
Dronedarone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000589	0.00659	CbGeAlD
Dronedarone—CACNB2—nervous system—acquired immunodeficiency syndrome	0.000588	0.00658	CbGeAlD
Dronedarone—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000586	0.00393	CcSEcCtD
Dronedarone—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000584	0.00391	CcSEcCtD
Dronedarone—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000584	0.00391	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000582	0.0039	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00058	0.00388	CcSEcCtD
Dronedarone—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00058	0.00388	CcSEcCtD
Dronedarone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000579	0.00649	CbGeAlD
Dronedarone—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000578	0.00387	CcSEcCtD
Dronedarone—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000575	0.00385	CcSEcCtD
Dronedarone—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000574	0.00385	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000571	0.00383	CcSEcCtD
Dronedarone—SCN1A—nervous system—acquired immunodeficiency syndrome	0.000571	0.0064	CbGeAlD
Dronedarone—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000569	0.00381	CcSEcCtD
Dronedarone—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000568	0.0038	CcSEcCtD
Dronedarone—CACNB2—central nervous system—acquired immunodeficiency syndrome	0.000566	0.00634	CbGeAlD
Dronedarone—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000563	0.00377	CcSEcCtD
Dronedarone—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000561	0.00376	CcSEcCtD
Dronedarone—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000559	0.00375	CcSEcCtD
Dronedarone—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000559	0.00374	CcSEcCtD
Dronedarone—CACNA1D—lung—acquired immunodeficiency syndrome	0.000555	0.00621	CbGeAlD
Dronedarone—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.000551	0.00369	CcSEcCtD
Dronedarone—SCN1A—central nervous system—acquired immunodeficiency syndrome	0.00055	0.00616	CbGeAlD
Dronedarone—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000549	0.00368	CcSEcCtD
Dronedarone—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000546	0.00366	CcSEcCtD
Dronedarone—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000545	0.00365	CcSEcCtD
Dronedarone—Angioedema—Zidovudine—acquired immunodeficiency syndrome	0.000545	0.00365	CcSEcCtD
Dronedarone—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000544	0.00364	CcSEcCtD
Dronedarone—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000544	0.00364	CcSEcCtD
Dronedarone—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000543	0.00364	CcSEcCtD
Dronedarone—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000542	0.00363	CcSEcCtD
Dronedarone—CACNA1C—vagina—acquired immunodeficiency syndrome	0.000541	0.00606	CbGeAlD
Dronedarone—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.000541	0.00362	CcSEcCtD
Dronedarone—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.00054	0.00362	CcSEcCtD
Dronedarone—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000536	0.00359	CcSEcCtD
Dronedarone—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000527	0.00353	CcSEcCtD
Dronedarone—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.000524	0.00351	CcSEcCtD
Dronedarone—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000521	0.00583	CbGeAlD
Dronedarone—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000515	0.00345	CcSEcCtD
Dronedarone—CACNA1D—nervous system—acquired immunodeficiency syndrome	0.000514	0.00575	CbGeAlD
Dronedarone—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000513	0.00344	CcSEcCtD
Dronedarone—CACNA1C—lung—acquired immunodeficiency syndrome	0.000512	0.00573	CbGeAlD
Dronedarone—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00051	0.00341	CcSEcCtD
Dronedarone—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000509	0.0057	CbGeAlD
Dronedarone—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000507	0.0034	CcSEcCtD
Dronedarone—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000507	0.00339	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000504	0.00338	CcSEcCtD
Dronedarone—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000501	0.00336	CcSEcCtD
Dronedarone—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000501	0.00561	CbGeAlD
Dronedarone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000501	0.00335	CcSEcCtD
Dronedarone—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.0005	0.00335	CcSEcCtD
Dronedarone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.0005	0.00335	CcSEcCtD
Dronedarone—CACNA1D—central nervous system—acquired immunodeficiency syndrome	0.000494	0.00554	CbGeAlD
Dronedarone—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000494	0.00331	CcSEcCtD
Dronedarone—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000494	0.00331	CcSEcCtD
Dronedarone—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000493	0.0033	CcSEcCtD
Dronedarone—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000491	0.00329	CcSEcCtD
Dronedarone—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00049	0.00549	CbGeAlD
Dronedarone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000487	0.00326	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000485	0.00325	CcSEcCtD
Dronedarone—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000484	0.00324	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000483	0.00324	CcSEcCtD
Dronedarone—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000483	0.00324	CcSEcCtD
Dronedarone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000483	0.00323	CcSEcCtD
Dronedarone—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000481	0.00322	CcSEcCtD
Dronedarone—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00048	0.00321	CcSEcCtD
Dronedarone—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000479	0.00321	CcSEcCtD
Dronedarone—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000477	0.0032	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000476	0.00319	CcSEcCtD
Dronedarone—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000476	0.00319	CcSEcCtD
Dronedarone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000475	0.00318	CcSEcCtD
Dronedarone—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000474	0.00318	CcSEcCtD
Dronedarone—CACNA1C—nervous system—acquired immunodeficiency syndrome	0.000474	0.00531	CbGeAlD
Dronedarone—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.00317	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000469	0.00314	CcSEcCtD
Dronedarone—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000465	0.00311	CcSEcCtD
Dronedarone—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000463	0.0031	CcSEcCtD
Dronedarone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000463	0.0031	CcSEcCtD
Dronedarone—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000462	0.00309	CcSEcCtD
Dronedarone—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000459	0.00308	CcSEcCtD
Dronedarone—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000458	0.00307	CcSEcCtD
Dronedarone—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000458	0.00307	CcSEcCtD
Dronedarone—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000458	0.00307	CcSEcCtD
Dronedarone—CACNA1C—central nervous system—acquired immunodeficiency syndrome	0.000456	0.00511	CbGeAlD
Dronedarone—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000456	0.00306	CcSEcCtD
Dronedarone—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000454	0.00304	CcSEcCtD
Dronedarone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000453	0.00303	CcSEcCtD
Dronedarone—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000451	0.00302	CcSEcCtD
Dronedarone—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00045	0.00301	CcSEcCtD
Dronedarone—CACNB2—brain—acquired immunodeficiency syndrome	0.000449	0.00503	CbGeAlD
Dronedarone—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000446	0.00299	CcSEcCtD
Dronedarone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000446	0.00299	CcSEcCtD
Dronedarone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000446	0.00298	CcSEcCtD
Dronedarone—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000444	0.00297	CcSEcCtD
Dronedarone—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000444	0.00297	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000443	0.00297	CcSEcCtD
Dronedarone—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000443	0.00296	CcSEcCtD
Dronedarone—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000442	0.00296	CcSEcCtD
Dronedarone—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000441	0.00296	CcSEcCtD
Dronedarone—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000441	0.00295	CcSEcCtD
Dronedarone—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00294	CcSEcCtD
Dronedarone—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000437	0.00293	CcSEcCtD
Dronedarone—SCN1A—brain—acquired immunodeficiency syndrome	0.000437	0.00489	CbGeAlD
Dronedarone—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000436	0.00292	CcSEcCtD
Dronedarone—CACNB2—lymph node—acquired immunodeficiency syndrome	0.000434	0.00486	CbGeAlD
Dronedarone—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00287	CcSEcCtD
Dronedarone—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000426	0.00285	CcSEcCtD
Dronedarone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00042	0.00281	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.00281	CcSEcCtD
Dronedarone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.00281	CcSEcCtD
Dronedarone—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000419	0.00281	CcSEcCtD
Dronedarone—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000417	0.00279	CcSEcCtD
Dronedarone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000417	0.00467	CbGeAlD
Dronedarone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000416	0.00279	CcSEcCtD
Dronedarone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000415	0.00278	CcSEcCtD
Dronedarone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00041	0.00275	CcSEcCtD
Dronedarone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00041	0.00275	CcSEcCtD
Dronedarone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000407	0.00272	CcSEcCtD
Dronedarone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000406	0.00272	CcSEcCtD
Dronedarone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000403	0.0027	CcSEcCtD
Dronedarone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000402	0.00269	CcSEcCtD
Dronedarone—ADRB1—lung—acquired immunodeficiency syndrome	0.000399	0.00447	CbGeAlD
Dronedarone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000398	0.00267	CcSEcCtD
Dronedarone—ADRA1B—brain—acquired immunodeficiency syndrome	0.000398	0.00446	CbGeAlD
Dronedarone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000398	0.00267	CcSEcCtD
Dronedarone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.00266	CcSEcCtD
Dronedarone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000397	0.00266	CcSEcCtD
Dronedarone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000397	0.00266	CcSEcCtD
Dronedarone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000396	0.00265	CcSEcCtD
Dronedarone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000396	0.00265	CcSEcCtD
Dronedarone—CACNA1D—brain—acquired immunodeficiency syndrome	0.000393	0.0044	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000392	0.00262	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000391	0.00262	CcSEcCtD
Dronedarone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00039	0.00261	CcSEcCtD
Dronedarone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00039	0.00261	CcSEcCtD
Dronedarone—ADRA1D—brain—acquired immunodeficiency syndrome	0.000389	0.00436	CbGeAlD
Dronedarone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.0026	CcSEcCtD
Dronedarone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000385	0.00258	CcSEcCtD
Dronedarone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000384	0.00257	CcSEcCtD
Dronedarone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000383	0.00257	CcSEcCtD
Dronedarone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000383	0.00257	CcSEcCtD
Dronedarone—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000383	0.00429	CbGeAlD
Dronedarone—CACNA1D—lymph node—acquired immunodeficiency syndrome	0.000379	0.00425	CbGeAlD
Dronedarone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000377	0.00253	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000377	0.00253	CcSEcCtD
Dronedarone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00252	CcSEcCtD
Dronedarone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00248	CcSEcCtD
Dronedarone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00037	0.00248	CcSEcCtD
Dronedarone—ADRB1—nervous system—acquired immunodeficiency syndrome	0.00037	0.00414	CbGeAlD
Dronedarone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00247	CcSEcCtD
Dronedarone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000369	0.00247	CcSEcCtD
Dronedarone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00247	CcSEcCtD
Dronedarone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00246	CcSEcCtD
Dronedarone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000366	0.00245	CcSEcCtD
Dronedarone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000365	0.00245	CcSEcCtD
Dronedarone—CACNA1C—brain—acquired immunodeficiency syndrome	0.000362	0.00406	CbGeAlD
Dronedarone—ADRA1A—blood—acquired immunodeficiency syndrome	0.00036	0.00404	CbGeAlD
Dronedarone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00241	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00036	0.00241	CcSEcCtD
Dronedarone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000358	0.0024	CcSEcCtD
Dronedarone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00239	CcSEcCtD
Dronedarone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000357	0.00239	CcSEcCtD
Dronedarone—ADRB1—central nervous system—acquired immunodeficiency syndrome	0.000356	0.00399	CbGeAlD
Dronedarone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000356	0.00238	CcSEcCtD
Dronedarone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000354	0.00237	CcSEcCtD
Dronedarone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000354	0.00237	CcSEcCtD
Dronedarone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00237	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00237	CcSEcCtD
Dronedarone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000353	0.00236	CcSEcCtD
Dronedarone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000353	0.00236	CcSEcCtD
Dronedarone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000353	0.00236	CcSEcCtD
Dronedarone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000351	0.00235	CcSEcCtD
Dronedarone—CACNA1C—lymph node—acquired immunodeficiency syndrome	0.00035	0.00392	CbGeAlD
Dronedarone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00035	0.00234	CcSEcCtD
Dronedarone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000349	0.00234	CcSEcCtD
Dronedarone—KCNH2—blood—acquired immunodeficiency syndrome	0.000348	0.0039	CbGeAlD
Dronedarone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000348	0.00233	CcSEcCtD
Dronedarone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000347	0.00233	CcSEcCtD
Dronedarone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00233	CcSEcCtD
Dronedarone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000344	0.00231	CcSEcCtD
Dronedarone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000344	0.00231	CcSEcCtD
Dronedarone—ADRA2C—blood—acquired immunodeficiency syndrome	0.000343	0.00385	CbGeAlD
Dronedarone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00228	CcSEcCtD
Dronedarone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00226	CcSEcCtD
Dronedarone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00226	CcSEcCtD
Dronedarone—KCNH2—bone marrow—acquired immunodeficiency syndrome	0.000337	0.00377	CbGeAlD
Dronedarone—KCNH2—spinal cord—acquired immunodeficiency syndrome	0.000335	0.00376	CbGeAlD
Dronedarone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000335	0.00224	CcSEcCtD
Dronedarone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000334	0.00223	CcSEcCtD
Dronedarone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00223	CcSEcCtD
Dronedarone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00223	CcSEcCtD
Dronedarone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000333	0.00223	CcSEcCtD
Dronedarone—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000331	0.00371	CbGeAlD
Dronedarone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000328	0.00219	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00219	CcSEcCtD
Dronedarone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000326	0.00218	CcSEcCtD
Dronedarone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000325	0.00217	CcSEcCtD
Dronedarone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00217	CcSEcCtD
Dronedarone—KCNH2—vagina—acquired immunodeficiency syndrome	0.000323	0.00361	CbGeAlD
Dronedarone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000321	0.00215	CcSEcCtD
Dronedarone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00032	0.00214	CcSEcCtD
Dronedarone—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000318	0.00356	CbGeAlD
Dronedarone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.00211	CcSEcCtD
Dronedarone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000314	0.0021	CcSEcCtD
Dronedarone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00207	CcSEcCtD
Dronedarone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000309	0.00207	CcSEcCtD
Dronedarone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000309	0.00207	CcSEcCtD
Dronedarone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000307	0.00205	CcSEcCtD
Dronedarone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.00205	CcSEcCtD
Dronedarone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000307	0.00205	CcSEcCtD
Dronedarone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000306	0.00205	CcSEcCtD
Dronedarone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00203	CcSEcCtD
Dronedarone—ADRA2C—lung—acquired immunodeficiency syndrome	0.000301	0.00337	CbGeAlD
Dronedarone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.00201	CcSEcCtD
Dronedarone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.00201	CcSEcCtD
Dronedarone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.002	CcSEcCtD
Dronedarone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.00199	CcSEcCtD
Dronedarone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00197	CcSEcCtD
Dronedarone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00196	CcSEcCtD
Dronedarone—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000292	0.00328	CbGeAlD
Dronedarone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00194	CcSEcCtD
Dronedarone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.00194	CcSEcCtD
Dronedarone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00193	CcSEcCtD
Dronedarone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000288	0.00193	CcSEcCtD
Dronedarone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000285	0.00191	CcSEcCtD
Dronedarone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000285	0.00191	CcSEcCtD
Dronedarone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.0019	CcSEcCtD
Dronedarone—ADRB1—brain—acquired immunodeficiency syndrome	0.000283	0.00317	CbGeAlD
Dronedarone—KCNH2—nervous system—acquired immunodeficiency syndrome	0.000282	0.00316	CbGeAlD
Dronedarone—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000282	0.00315	CbGeAlD
Dronedarone—ALB—brain—acquired immunodeficiency syndrome	0.000281	0.00315	CbGeAlD
Dronedarone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00187	CcSEcCtD
Dronedarone—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000279	0.00312	CbGeAlD
Dronedarone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000275	0.00184	CcSEcCtD
Dronedarone—ADRA2A—blood—acquired immunodeficiency syndrome	0.000274	0.00307	CbGeAlD
Dronedarone—KCNH2—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00305	CbGeAlD
Dronedarone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000272	0.00182	CcSEcCtD
Dronedarone—ALB—lymph node—acquired immunodeficiency syndrome	0.000272	0.00304	CbGeAlD
Dronedarone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00182	CcSEcCtD
Dronedarone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00181	CcSEcCtD
Dronedarone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.0018	CcSEcCtD
Dronedarone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000269	0.0018	CcSEcCtD
Dronedarone—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000268	0.00301	CbGeAlD
Dronedarone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00179	CcSEcCtD
Dronedarone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000264	0.00296	CbGeAlD
Dronedarone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00175	CcSEcCtD
Dronedarone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00026	0.00174	CcSEcCtD
Dronedarone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00173	CcSEcCtD
Dronedarone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.00173	CcSEcCtD
Dronedarone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.00173	CcSEcCtD
Dronedarone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00173	CcSEcCtD
Dronedarone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.0017	CcSEcCtD
Dronedarone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000254	0.00284	CbGeAlD
Dronedarone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00167	CcSEcCtD
Dronedarone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00167	CcSEcCtD
Dronedarone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00165	CcSEcCtD
Dronedarone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00163	CcSEcCtD
Dronedarone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.00161	CcSEcCtD
Dronedarone—ADRA2A—lung—acquired immunodeficiency syndrome	0.00024	0.00269	CbGeAlD
Dronedarone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.0016	CcSEcCtD
Dronedarone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.0016	CcSEcCtD
Dronedarone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00159	CcSEcCtD
Dronedarone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00155	CcSEcCtD
Dronedarone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.00154	CcSEcCtD
Dronedarone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00154	CcSEcCtD
Dronedarone—ABCB1—retina—acquired immunodeficiency syndrome	0.000228	0.00256	CbGeAlD
Dronedarone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000226	0.00254	CbGeAlD
Dronedarone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000225	0.00151	CcSEcCtD
Dronedarone—ADRA1A—brain—acquired immunodeficiency syndrome	0.000224	0.0025	CbGeAlD
Dronedarone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000223	0.0025	CbGeAlD
Dronedarone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000222	0.00249	CbGeAlD
Dronedarone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00148	CcSEcCtD
Dronedarone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00147	CcSEcCtD
Dronedarone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00147	CcSEcCtD
Dronedarone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00145	CcSEcCtD
Dronedarone—KCNH2—brain—acquired immunodeficiency syndrome	0.000216	0.00242	CbGeAlD
Dronedarone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000216	0.00242	CbGeAlD
Dronedarone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000214	0.0024	CbGeAlD
Dronedarone—ADRA2C—brain—acquired immunodeficiency syndrome	0.000213	0.00239	CbGeAlD
Dronedarone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000212	0.00238	CbGeAlD
Dronedarone—KCNH2—lymph node—acquired immunodeficiency syndrome	0.000209	0.00234	CbGeAlD
Dronedarone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00138	CcSEcCtD
Dronedarone—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000206	0.00231	CbGeAlD
Dronedarone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000175	0.00196	CbGeAlD
Dronedarone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000172	0.00193	CbGeAlD
Dronedarone—ADRA2A—brain—acquired immunodeficiency syndrome	0.00017	0.0019	CbGeAlD
Dronedarone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000169	0.00189	CbGeAlD
Dronedarone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000166	0.00186	CbGeAlD
Dronedarone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000164	0.00184	CbGeAlD
Dronedarone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000162	0.00182	CbGeAlD
Dronedarone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00016	0.00179	CbGeAlD
Dronedarone—ABCB1—blood—acquired immunodeficiency syndrome	0.000153	0.00171	CbGeAlD
Dronedarone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000148	0.00165	CbGeAlD
Dronedarone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000147	0.00165	CbGeAlD
Dronedarone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000141	0.00158	CbGeAlD
Dronedarone—ABCB1—lung—acquired immunodeficiency syndrome	0.000134	0.0015	CbGeAlD
Dronedarone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000132	0.00147	CbGeAlD
Dronedarone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000124	0.00139	CbGeAlD
Dronedarone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000119	0.00134	CbGeAlD
Dronedarone—ABCB1—brain—acquired immunodeficiency syndrome	9.47e-05	0.00106	CbGeAlD
Dronedarone—ABCB1—lymph node—acquired immunodeficiency syndrome	9.15e-05	0.00103	CbGeAlD
Dronedarone—CACNB1—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.59e-05	0.000861	CbGpPWpGaD
Dronedarone—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.58e-05	0.000858	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.55e-05	0.00085	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.54e-05	0.000845	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.54e-05	0.000845	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.000845	CbGpPWpGaD
Dronedarone—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.54e-05	0.000845	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.000838	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.47e-05	0.000822	CbGpPWpGaD
Dronedarone—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2.46e-05	0.000821	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.46e-05	0.000819	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.45e-05	0.000816	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.45e-05	0.000815	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.44e-05	0.000811	CbGpPWpGaD
Dronedarone—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.42e-05	0.000807	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.41e-05	0.000801	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.36e-05	0.000786	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.36e-05	0.000786	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.35e-05	0.000781	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.34e-05	0.00078	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.34e-05	0.000779	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.34e-05	0.000779	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.34e-05	0.000779	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.31e-05	0.00077	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.31e-05	0.00077	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.3e-05	0.000767	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.3e-05	0.000767	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.29e-05	0.000763	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.29e-05	0.000763	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.29e-05	0.000761	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.28e-05	0.000758	CbGpPWpGaD
Dronedarone—CACNB2—Axon guidance—IL6—acquired immunodeficiency syndrome	2.28e-05	0.000758	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.000755	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.25e-05	0.000749	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.24e-05	0.000746	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.23e-05	0.000744	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—ALB—acquired immunodeficiency syndrome	2.22e-05	0.000738	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.21e-05	0.000737	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.19e-05	0.000728	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.19e-05	0.000728	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.16e-05	0.000719	CbGpPWpGaD
Dronedarone—CACNA1D—Axon guidance—IL6—acquired immunodeficiency syndrome	2.15e-05	0.000717	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.15e-05	0.000716	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.15e-05	0.000716	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.14e-05	0.000712	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.14e-05	0.000712	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.14e-05	0.000711	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.12e-05	0.000704	CbGpPWpGaD
Dronedarone—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000704	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.11e-05	0.000702	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.11e-05	0.000701	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.11e-05	0.000701	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.1e-05	0.000699	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.1e-05	0.000699	CbGpPWpGaD
Dronedarone—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	2.1e-05	0.000698	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.08e-05	0.000693	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.08e-05	0.000693	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.08e-05	0.000692	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.07e-05	0.000688	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.06e-05	0.000686	CbGpPWpGaD
Dronedarone—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000682	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.04e-05	0.000678	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.03e-05	0.000677	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.01e-05	0.00067	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2e-05	0.000665	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.99e-05	0.000662	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.98e-05	0.000658	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.95e-05	0.000648	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.000647	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.000647	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.94e-05	0.000647	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.000643	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.91e-05	0.000637	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.91e-05	0.000637	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.91e-05	0.000636	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.91e-05	0.000636	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.91e-05	0.000634	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.000633	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.89e-05	0.000631	CbGpPWpGaD
Dronedarone—CACNA1C—Axon guidance—IL6—acquired immunodeficiency syndrome	1.89e-05	0.00063	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.87e-05	0.000623	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.87e-05	0.000623	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.86e-05	0.000618	CbGpPWpGaD
Dronedarone—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.85e-05	0.000617	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.85e-05	0.000616	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.84e-05	0.000611	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.81e-05	0.000602	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.78e-05	0.000591	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.78e-05	0.000591	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—ALB—acquired immunodeficiency syndrome	1.77e-05	0.000589	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.76e-05	0.000586	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.75e-05	0.000584	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.00058	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.000579	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.74e-05	0.000579	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.74e-05	0.000579	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.000577	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.73e-05	0.000576	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.73e-05	0.000575	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.73e-05	0.000575	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.72e-05	0.000572	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.7e-05	0.000566	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.7e-05	0.000566	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.68e-05	0.000559	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—TNF—acquired immunodeficiency syndrome	1.67e-05	0.000557	CbGpPWpGaD
Dronedarone—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000555	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	1.65e-05	0.000551	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.63e-05	0.000542	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.63e-05	0.000542	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.62e-05	0.000541	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.61e-05	0.000534	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000534	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.6e-05	0.000533	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.6e-05	0.000533	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.6e-05	0.000532	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.000528	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.58e-05	0.000527	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.58e-05	0.000526	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.58e-05	0.000526	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.58e-05	0.000526	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.58e-05	0.000525	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.57e-05	0.000524	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.57e-05	0.000523	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.56e-05	0.000519	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000512	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.54e-05	0.000512	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000492	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000488	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.46e-05	0.000486	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.000485	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.46e-05	0.000484	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.45e-05	0.000482	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.45e-05	0.000481	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000481	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000479	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	1.44e-05	0.000478	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.43e-05	0.000477	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.43e-05	0.000475	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000474	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000467	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.37e-05	0.000455	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.36e-05	0.000453	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.36e-05	0.000453	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—ALB—acquired immunodeficiency syndrome	1.35e-05	0.000451	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—IL6—acquired immunodeficiency syndrome	1.35e-05	0.00045	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.35e-05	0.00045	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.34e-05	0.000447	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	1.34e-05	0.000446	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000443	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.33e-05	0.000443	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.33e-05	0.000442	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.32e-05	0.00044	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000439	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.31e-05	0.000436	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.31e-05	0.000435	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.3e-05	0.000434	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.29e-05	0.00043	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—ALB—acquired immunodeficiency syndrome	1.28e-05	0.000427	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000427	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.27e-05	0.000424	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000413	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000413	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.23e-05	0.000409	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.23e-05	0.000409	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.22e-05	0.000407	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.2e-05	0.0004	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.0004	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.2e-05	0.000398	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000397	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000394	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.18e-05	0.000393	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.16e-05	0.000388	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.15e-05	0.000382	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.15e-05	0.000382	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.13e-05	0.000377	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.13e-05	0.000376	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.13e-05	0.000376	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-05	0.000375	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.1e-05	0.000365	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000363	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.00036	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.07e-05	0.000355	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.04e-05	0.000345	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.02e-05	0.00034	CbGpPWpGaD
Dronedarone—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1e-05	0.000335	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1e-05	0.000334	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1e-05	0.000334	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.92e-06	0.00033	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.44e-06	0.000314	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.35e-06	0.000311	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.33e-06	0.000311	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.32e-06	0.00031	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.32e-06	0.00031	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.29e-06	0.000309	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.21e-06	0.000307	CbGpPWpGaD
Dronedarone—ADRB1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.16e-06	0.000305	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.13e-06	0.000304	CbGpPWpGaD
Dronedarone—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.07e-06	0.000302	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.73e-06	0.000291	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.6e-06	0.000286	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	8.6e-06	0.000286	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.6e-06	0.000286	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.5e-06	0.000283	CbGpPWpGaD
Dronedarone—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.47e-06	0.000282	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.47e-06	0.000282	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.42e-06	0.00028	CbGpPWpGaD
Dronedarone—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.34e-06	0.000278	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.31e-06	0.000277	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.24e-06	0.000274	CbGpPWpGaD
Dronedarone—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.04e-06	0.000268	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.87e-06	0.000262	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.74e-06	0.000258	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.7e-06	0.000256	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.64e-06	0.000254	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.57e-06	0.000252	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.52e-06	0.00025	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.41e-06	0.000247	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.09e-06	0.000236	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.99e-06	0.000233	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.88e-06	0.000229	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.88e-06	0.000229	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.73e-06	0.000224	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	6.7e-06	0.000223	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.39e-06	0.000213	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.25e-06	0.000208	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.45e-06	0.000181	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.39e-06	0.000179	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.36e-06	0.000179	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.91e-06	0.000164	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.89e-06	0.000163	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.87e-06	0.000162	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.84e-06	0.000161	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.55e-06	0.000151	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.52e-06	0.000151	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.47e-06	0.000149	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.45e-06	0.000148	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.97e-06	0.000132	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.95e-06	0.000132	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.77e-06	0.000125	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.69e-06	0.000123	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.67e-06	0.000122	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.55e-06	0.000118	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.17e-06	0.000105	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.89e-06	9.61e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.86e-06	9.52e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.67e-06	8.9e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.63e-06	8.76e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.34e-06	7.78e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.32e-06	7.72e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.17e-06	7.23e-05	CbGpPWpGaD
